Michael Powell, Director, 10% Owner at Mirna Therapeutics, Inc. (MIRN), bought 2,391,252 shares at $7.00 ($6.0M) on 2015-10-06, disclosed to the SEC on 2015-10-06.
Open-market purchase of $6.0M MIRN by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,244,269 | $0 | 0.0% |
| 2 | $0.00 | 289,841 | $0 | 0.0% |
| 3 | $7.00 | 857,142 | $6.0M | 100.0% |
| Total | $2.51 avg | 2,391,252 | $6.0M | 100% |
| Filing → |
| OCRX | SELL | 2016-12-30 | $15K | — | Filing → |
| AERI | SELL | 2014-07-11 | $24.2M | — | Filing → |
| HPTX | SELL | 2014-03-05 | $709K | — | Filing → |